Keyword

H101

Description: A genetically modified oncolytic adenovirus developed as a cancer therapy, investigated for treating solid tumors.
OpenAlex ID: keywords/h101
2006 · Ken Garber · JNCI Journal of the National Cancer Institute · 583
2018 · Min Liang · Current Cancer Drug Targets · 356
2007 · Wang Yu, Hu Fang · Current Cancer Drug Targets · 292
2007 · Anne Moon Crompton, David Kirn · Current Cancer Drug Targets · 128
2019 · Claudia Hill, Robert Carlisle · Expert Opinion on Drug Delivery · 89
2015 · Pei-Hsin Cheng, Stephen Wechman, et al. · Viruses · 74
2022 · Ke Li, Yalong Zhao, et al. · PubMed · 55
2008 · He Zhang, Haibo Wang, et al. · Molecular Therapy · 45
2015 · JIE LEI, QI-HUA LI, et al. · International Journal of Oncology · 37
2009 · Pin-I Huang, Ju-Fang Chang, et al. · Drug Discovery Today · 36
2012 · Gunnel Halldén, Giuseppe Portella · Expert Opinion on Therapeutic Targets · 34
2004 · J. Andrew Pearce, Kerry Mills, et al. · Molecular and Biochemical Parasitology · 33
2010 · Xin Song, Yixiong Zhou, et al. · Investigative Ophthalmology & Visual Science · 30
2007 · H. Kasuya, S. Takeda, et al. · Current Cancer Drug Targets · 23
Works count: 93
Citation count: 2,350
Year
Topic
Type